Home/Filings/4/0001415889-25-014257
4//SEC Filing

Farnum Rhonda 4

Accession 0001415889-25-014257

CIK 0001583107other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 6:39 PM ET

Size

4.9 KB

Accession

0001415889-25-014257

Insider Transaction Report

Form 4
Period: 2025-05-20
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Transactions
  • Tax Payment

    Ordinary Shares

    2025-05-20$9.45/sh9,120$86,184360,918 total
Footnotes (1)
  • [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001898490

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 6:39 PM ET
Size
4.9 KB